Exploring the ability of vocal biomarkers in distinguishing depression from bipolar disorder, schizophrenia, and healthy controls

被引:3
|
作者
Pan, Wei [1 ,2 ,3 ]
Deng, Fusong [4 ]
Wang, Xianbin [1 ,2 ,3 ]
Hang, Bowen [1 ,2 ,3 ]
Zhou, Wenwei [1 ,2 ,3 ]
Zhu, Tingshao [5 ,6 ]
机构
[1] Minist Educ, Key Lab Adolescent Cyberpsychol & Behav CCNU, Wuhan, Peoples R China
[2] Cent China Normal Univ, Sch Psychol, Wuhan, Peoples R China
[3] Key Lab Human Dev & Mental Hlth Hubei Prov, Wuhan, Peoples R China
[4] Wuhan Univ Sci & Technol, Wuhan Wuchang Hosp, Wuchang Hosp, Wuhan, Peoples R China
[5] Chinese Acad Sci, Inst Psychol, Beijing, Peoples R China
[6] Chinese Acad Sci, Inst Psychol, CAS Key Lab Behav Sci, Beijing, Peoples R China
来源
FRONTIERS IN PSYCHIATRY | 2023年 / 14卷
关键词
depression; healthy controls; schizophrenia; bipolar disorder; i-vectors; logistic regression MFCCs; SPEECH EMOTION RECOGNITION; NEGATIVE SYMPTOMS; MATCHING METHODS; FEATURES; PERFORMANCE; EXPRESSION; DISEASES; PROSODY; MODELS;
D O I
10.3389/fpsyt.2023.1079448
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
BackgroundVocal features have been exploited to distinguish depression from healthy controls. While there have been some claims for success, the degree to which changes in vocal features are specific to depression has not been systematically studied. Hence, we examined the performances of vocal features in differentiating depression from bipolar disorder (BD), schizophrenia and healthy controls, as well as pairwise classifications for the three disorders. MethodsWe sampled 32 bipolar disorder patients, 106 depression patients, 114 healthy controls, and 20 schizophrenia patients. We extracted i-vectors from Mel-frequency cepstrum coefficients (MFCCs), and built logistic regression models with ridge regularization and 5-fold cross-validation on the training set, then applied models to the test set. There were seven classification tasks: any disorder versus healthy controls; depression versus healthy controls; BD versus healthy controls; schizophrenia versus healthy controls; depression versus BD; depression versus schizophrenia; BD versus schizophrenia. ResultsThe area under curve (AUC) score for classifying depression and bipolar disorder was 0.5 (F-score = 0.44). For other comparisons, the AUC scores ranged from 0.75 to 0.92, and the F-scores ranged from 0.73 to 0.91. The model performance (AUC) of classifying depression and bipolar disorder was significantly worse than that of classifying bipolar disorder and schizophrenia (corrected p < 0.05). While there were no significant differences in the remaining pairwise comparisons of the 7 classification tasks. ConclusionVocal features showed discriminatory potential in classifying depression and the healthy controls, as well as between depression and other mental disorders. Future research should systematically examine the mechanisms of voice features in distinguishing depression with other mental disorders and develop more sophisticated machine learning models so that voice can assist clinical diagnosis better.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Vitamin D deficiency in schizophrenia, bipolar disorder and major depressive disorder compared to healthy controls
    Cha, B.
    Shin, Y. M.
    Kim, Y. S.
    Kim, B. J.
    Lee, C. S.
    Sohn, J. W.
    Park, C. S.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2011, 21 : S429 - S430
  • [22] Executive dysfunction and memory impairment in schizoaffective disorder: a comparison with bipolar disorder, schizophrenia and healthy controls
    Amann, B.
    Gomar, J. J.
    Ortiz-Gil, J.
    McKenna, P.
    Sans-Sansa, B.
    Sarro, S.
    Moro, N.
    Madre, M.
    Landin-Romero, R.
    Vieta, E.
    Giokolea, J. M.
    Salvador, R.
    Pomarol-Clotet, E.
    PSYCHOLOGICAL MEDICINE, 2012, 42 (10) : 2127 - 2135
  • [23] MICROBIOTA FEATURES IN PARTICIPANTS WITH SEVERITY OF DEPRESSION AMONG THE BIPOLAR DISORDER AND HEALTHY CONTROLS
    Chuang, Li-Chung
    Chung, Yu-Chu Ella
    Shih, Wei-Liang
    Kuo, Po-Hsiu
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : 1304 - 1304
  • [24] Distinguishing affective depersonalization from anhedonia in major depression and bipolar disorder
    Mula, Marco
    Pini, Stefano
    Calugi, Simona
    Preve, Matteo
    Masini, Matteo
    Giovannini, Ilaria
    Rucci, Paola
    Cassano, Giovanni B.
    COMPREHENSIVE PSYCHIATRY, 2010, 51 (02) : 187 - 192
  • [26] The Influence of Vitamin D Status on Cognitive Ability in Patients with Bipolar Disorder and Healthy Controls
    Leser, Bernadette
    Dalkner, Nina
    Tmava-Berisha, Adelina
    Fellendorf, Frederike T.
    Unterrainer, Human-Friedrich
    Stross, Tatjana
    Maget, Alexander
    Platzer, Martina
    Bengesser, Susanne A.
    Haussl, Alfred
    Zwigl, Ina
    Birner, Armin
    Queissner, Robert
    Stix, Katharina
    Wels, Linda
    Schonthaler, Elena M. D.
    Lenger, Melanie
    Schwerdtfeger, Andreas R.
    Zelzer, Sieglinde
    Herrmann, Markus
    Reininghaus, Eva Z.
    NUTRIENTS, 2023, 15 (19)
  • [27] Near-infrared spectroscopy of bipolar disorder may be distinct from that of unipolar depression and of healthy controls
    Shimodera, Shinji
    Imai, Yutaka
    Kamimura, Naoto
    Morokuma, Ippei
    Fujita, Hirokazu
    Inoue, Shimpei
    Furukawa, Toshi A.
    ASIA-PACIFIC PSYCHIATRY, 2012, 4 (04) : 258 - 265
  • [28] COMPARISON OF QUALITY OF LIFE BETWEEN PATIENTS WITH BIPOLAR AFECTIVE DISORDER, SCHIZOPHRENIA AND HEALTHY CONTROLS
    Latalova, K.
    Prasko, J.
    Diveky, T.
    Kamaradova, D.
    Velartova, H.
    Grambal, A.
    Cerna, M.
    Ociskova, M.
    Mainerova, B.
    Vrbova, K.
    EUROPEAN PSYCHIATRY, 2013, 28
  • [29] Cerebrospinal fluid biomarkers of neurodegeneration affect cognitive functions in bipolar disorder but not healthy controls
    Rolstad, S.
    Jakobsson, J.
    Sparding, T.
    Sellgren, C.
    Ekman, C. J.
    Blennow, K. A. J.
    Zetterberg, H.
    Palson, E.
    Landen, M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S426 - S426
  • [30] Differences in subcortical brain volumes among patients with schizophrenia and bipolar disorder and healthy controls
    Ohi, Kazutaka
    Ishibashi, Miori
    Torii, Kaai
    Hashimoto, Mayuka
    Yano, Yurika
    Shioiri, Toshiki
    JOURNAL OF PSYCHIATRY & NEUROSCIENCE, 2022, 47 (02): : E77 - E85